MEI Pharma Inc (NAS:MEIP)
$ 2.88 0.08 (2.86%) Market Cap: 19.19 Mil Enterprise Value: -26.23 Mil PE Ratio: 0.73 PB Ratio: 0.38 GF Score: 53/100

Q4 2021 MEI Pharma Inc Earnings Call Transcript

Sep 02, 2021 / 09:00PM GMT
Release Date Price: $58 (+2.47%)
Operator

Good afternoon, and welcome to the MEI Pharma 2021 Fiscal Year-End Conference Call. Please note that the call is being recorded. At this time, I would like to turn the call over to David Walsey, MEI's Senior Vice President, Corporate Affairs. Please proceed.

David A. Walsey
MEI Pharma, Inc. - SVP of Corporate Affairs

Thank you. Good afternoon, everyone, and thank you for joining us. After the market closed today, we filed our Form 10-K for the fiscal year ended June 30, 2021, with the Securities and Exchange Commission and issued our financial results and corporate highlights press release, both of which are available on our website at www.meipharma.com.

On our call today, we will provide a summary of financials from the fiscal year ended June 30, 2021, and then review progress in our programs and business over the last year. We will then open the call to your questions.

Before we get started, I want to call your attention to the fact that this conference call may contain

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot